MTOR and cancer: Little is known about pharmaceutical agents targeting cFLIP in cancer cells, but some therapeutic agents have been shown to downregulate cFLIP, including histone deacetylase inhibitors [38, 39], mTOR inhibitors [40, 41], proteasome inhibitors [42, 43], and a Cox-2 inhibitor [44].